Drug Class: DPP-4 Inhibitor + Biguanide Antidiabetic Combination | Form: Extended-Release Oral Tablet | Prescription Status: Prescription Only (Rx) — DRAP Registered
What is Tagipmet XR 100/1000mg Tablet? Tagipmet XR 100/1000mg contains the full standard Sitagliptin 100mg dose and the maximum therapeutic Metformin Hydrochloride 1000mg dose in a single extended-release tablet — the highest strength Tagipmet XR combination representing the standard target maintenance dose for most Type 2 diabetic adults with normal kidney function requiring comprehensive dual antidiabetic coverage. This combination delivers both maximum DPP-4 inhibition from full-dose Sitagliptin and strongest hepatic glucose suppression and insulin sensitisation from high-dose Metformin — providing the most comprehensive glycaemic control achievable from this two-medicine combination. The XR formulation maintains the significantly improved gastrointestinal tolerability advantage even at this highest Metformin dose — making twice-daily dosing with meals the optimal regimen for maximum efficacy and tolerability throughout long-term diabetes management.
What is Tagipmet XR 100/1000mg Used For?
- Type 2 diabetes — maximum strength dual combination maintenance therapy for normal kidney function patients (ذیابیطس ٹائپ 2 میں زیادہ سے زیادہ بلڈ شوگر کنٹرول)
- Target maintenance dose — patients successfully uptitrated from 100/500mg starting combination
- Established dual antidiabetic therapy — replacing separate Sitagliptin 100mg and Metformin XR 1000mg tablets
- Type 2 diabetes with significant insulin resistance — maximum Metformin dose provides strongest insulin-sensitising effect (شدید انسولین مزاحمت میں زیادہ سے زیادہ علاج)
- Overweight and obese Type 2 diabetic patients — maximum Metformin weight-neutral to modest weight-reducing benefit
- Patients not achieving HbA1c targets on 100/500mg — uptitration to maximum combination strength
How Does it Work? Sitagliptin 100mg achieves complete and sustained DPP-4 enzyme inhibition — maximally elevating active GLP-1 and GIP incretin levels to stimulate full glucose-dependent insulin secretion and maximally suppress glucagon, providing strongest postprandial glucose control with inherently low hypoglycaemia risk. Metformin 1000mg delivers its maximum clinical hepatic action — strongly inhibiting gluconeogenesis and glycogenolysis to produce the greatest reduction in fasting hepatic glucose output, the primary driver of elevated HbA1c. At 1000mg Metformin also achieves maximum peripheral insulin sensitisation in muscle and adipose tissue and strongest intestinal glucose absorption reduction. The XR mechanism releases 1000mg Metformin gradually over several hours — distributing absorption across the upper gastrointestinal tract for maximum efficacy with minimum peak gastrointestinal drug concentrations and consequent side effects.
Dosage and Administration
⚠️ Swallow whole — never crush, break, or chew the extended-release tablet. Take with meals — twice daily dosing with morning and evening meals provides optimal blood sugar coverage. Stop before iodinated contrast imaging — lactic acidosis risk amplified at maximum Metformin dose. Monitor kidney function regularly. Never exceed total daily Metformin 2000mg from all sources combined.
| Indication | Usual Adult Dose | Frequency | Notes |
|---|---|---|---|
| Target maintenance — Type 2 diabetes | 100mg/1000mg | Twice daily with meals | Morning and evening meal |
| Uptitration from 100/500mg | 100mg/1000mg | Twice daily with meals | After tolerability confirmed at lower dose |
| Replacing separate tablets | 100mg/1000mg | Twice daily with meals | Equivalent to separate 100mg + 1000mg tablets |
| Maximum glycaemic control | 100mg/1000mg | Twice daily with meals | Under diabetologist supervision |
Active Ingredients
| Ingredient | Strength |
|---|---|
| Sitagliptin Phosphate Monohydrate | 100mg (as Sitagliptin) |
| Metformin Hydrochloride | 1000mg (Extended-Release) |
Who Should NOT Take Tagipmet XR 100/1000mg?
- Allergy to Sitagliptin, Metformin, or any component of the tablet
- Type 1 diabetes mellitus — not indicated
- Diabetic ketoacidosis — requires urgent insulin therapy
- Moderate to severe kidney impairment — GFR below 45ml/min; Metformin 1000mg strictly contraindicated and Sitagliptin requires dose reduction
- Severe liver impairment — Metformin lactic acidosis risk significantly elevated
- Acute conditions causing dehydration or tissue hypoxia — heart failure, respiratory failure, recent myocardial infarction, sepsis
- History of pancreatitis — Sitagliptin associated with pancreatitis risk
- Alcohol dependence — greatly amplifies lactic acidosis risk at maximum Metformin dose
- Planned iodinated contrast imaging — stop before procedure; restart only after kidney function confirmed normal
- Pregnancy and breastfeeding — insulin preferred during pregnancy
- Children under 18 years
Side Effects
Common: Mild nausea, mild stomach discomfort, mild diarrhoea — substantially reduced by XR formulation and twice-daily dosing with meals even at maximum 1000mg Metformin dose. Mild headache, mild metallic taste, mild upper respiratory symptoms — generally well tolerated with the extended-release mechanism at this highest strength.
Serious — Stop and seek emergency help immediately: Lactic acidosis — most critical risk at maximum Metformin dose; severe muscle pain, extreme difficulty breathing, severe abdominal pain, profound weakness, feeling cold, slow irregular heartbeat, dizziness and confusion (فوری ہسپتال جائیں — یہ سب سے خطرناک طبی ہنگامی صورتحال ہے — ایک لمحہ بھی دیر نہ کریں), acute pancreatitis — severe persistent upper abdominal pain radiating to back with nausea and vomiting (پیٹ میں شدید درد — فوری مدد لیں), severe allergic reaction — sudden swelling of face or throat with difficulty breathing (فوری ہسپتال جائیں), Stevens-Johnson syndrome — widespread blistering and peeling skin (فوری مدد لیں), significant disabling joint pain — severe arthralgia (جوڑوں کا شدید درد — ڈاکٹر کو بتائیں), worsening heart failure — breathlessness with severe ankle swelling (فوری مدد لیں), hypoglycaemia when combined with sulphonylurea or insulin (بلڈ شوگر کا گرنا — فوری میٹھا کھائیں).
Drug Interactions
| Medicine | Interaction |
|---|---|
| Iodinated contrast media | Stop minimum 48 hours before any contrast procedure — lactic acidosis risk maximally amplified at 1000mg Metformin; restart only after kidney function confirmed normal post-procedure |
| Sulphonylureas (Glibenclamide, Glimepiride) | Significantly increased hypoglycaemia risk — sulphonylurea dose reduction required |
| Insulin | Increased hypoglycaemia risk — careful insulin dose adjustment under specialist supervision |
| Alcohol (شراب) | Maximally increases lactic acidosis risk at highest Metformin dose — avoid completely without exception |
| Corticosteroids (Prednisolone) | Significantly raise blood glucose — monitor blood sugar very closely during any steroid course |
| Diuretics (Furosemide, Thiazides) | Dehydration increases lactic acidosis risk — most significant concern at maximum Metformin dose |
| ACE inhibitors / ARBs | May cause acute kidney impairment — Metformin 1000mg accumulates most rapidly with any renal decline |
| Cimetidine | Significantly increases Metformin blood levels — lactic acidosis risk maximally amplified at 1000mg dose |
| Beta-blockers | Mask hypoglycaemia warning signs — particularly important when combined with sulphonylurea or insulin |
| Topiramate / Carbonic anhydrase inhibitors | Increased lactic acidosis risk — avoid combination at maximum Metformin dose |
Storage: Store below 25°C in a cool, dry place. Protect from moisture and direct sunlight. Swallow whole — never break, crush, or chew. Keep out of reach of children (بچوں کی پہنچ سے دور رکھیں). Do not use after expiry date.
FAQs
Q: Is Tagipmet XR 100/1000mg the strongest available Tagipmet formulation and is it suitable for everyone with Type 2 diabetes? Yes — this is the highest available Tagipmet XR strength combining maximum doses of both components. However it is only appropriate for patients with normal kidney function — GFR above 60ml/min ideally. Patients with any degree of kidney impairment require lower strength formulations with reduced Sitagliptin and Metformin doses calibrated to their specific kidney function level.
Q: What happens if I accidentally miss a dose of Tagipmet XR 100/1000mg? Take the missed dose as soon as remembered with a meal — if it is almost time for the next dose skip the missed dose entirely and continue with the regular schedule. Never double up doses to compensate for a missed one as this doubles the Metformin exposure significantly increasing lactic acidosis and gastrointestinal side effect risk.
Q: How does Tagipmet XR 100/1000mg compare to adding a sulphonylurea for additional glycaemic control? Tagipmet XR 100/1000mg provides dual mechanism glycaemic control with very low intrinsic hypoglycaemia risk and weight neutrality. Adding a sulphonylurea as a third agent provides additional HbA1c lowering but significantly increases hypoglycaemia risk and promotes weight gain. Your diabetologist will assess whether triple therapy with a sulphonylurea or insulin provides better overall outcomes for your individual glycaemic targets and risk profile.
Medical Disclaimer: This information is for general awareness only and does not replace medical advice. Always consult a qualified doctor or pharmacist before taking any prescription medicine.